ghk-cu peptide dosage mg per day subcutaneous Dosage: Protocols & Charts GHK-CU Peptide Injection Dosage: Complete

Sensory Symptoms Numbness, tingling, or pins and needles (paresthesia) typically distal/stocking-glove in polyneuropathy Burning pain, allodynia, hyperalgesia common in small-fiber predominant neuropathy and CIDP Loss of proprioception and vibration sense sensory ataxia, positive Romberg sign Loss of pain/temperature sensation (small fiber) risk of unnoticed wounds Motor Symptoms Distal muscle weakness (foot drop in peroneal neuropathy, wrist drop in radial neuropathy) Atrophy of intrinsic hand muscles (ulnar/median neuropathy) Hyporeflexia or areflexia (ankle jerks lost early in length-dependent polyneuropathy) Fasciculations in severe axonal loss Autonomic Symptoms Orthostatic hypotension, dizziness on standing Gastroparesis, constipation or diarrhea, nausea Neurogenic bladder (hesitancy, retention, incontinence) Anhidrosis or gustatory sweating Sexual dysfunction

Depletion of holoTC by folic acid in individuals with already low vitamin B-12 status further compromises the availability of vitamin B-12 coenzymes to their respective enzymes, and consequently a more pronounced state of biochemical deficiency

Two predominant hypotheses have emerged: the outside-in model, where peripheral immune activation drives CNS demyelination, and the inside-out model, which posits that primary glial or axonal injury triggers the disease

Early life stress dysregulates kappa opioid receptor signaling within the lateral habenula

Improvement of neurological functions: Strengthens cognitive abilities by stimulating the production and activity of neurons, supports brain health

Advantages: Targets autoimmune-driven joint inflammation specifically